Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 25, 2026 20:00 ET | Source: AGC Biologics, Inc.

AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance

AGC Biologics will provide contract development and manufacturing services for Teikoku Seiyaku’s drug candidate to treat lumbar disc herniation.